News - Zdravlje Leskovac - Pharmaceutical and Chemicstry industry - Page 3


logo-zdravlje-blog-news.jpg
28/02/2022

On the occasion of the Rare Disease World Day, 28 February, Zdravlje is sharing the general public information to help raise the awareness and generate the change for the 300 million people worldwide living with a rare disease, their families and carers.

logo-zdravlje-blog-news.jpg
17/01/2022

Zdravlje is pleased to announce an important expansion of our commercial capabilities in Serbia. As of 10 January, Zdravlje has added five medical representatives who will be working directly with doctors and pharmacists to provide professional support, expertise and information on our high quality product portfolio.

zdravlje-borba-protiv-corona-virusa.jpg
22/10/2021

Approximately six months into new ownership Zdravlje A.D. (“Zdravlje”) is proud to announce the signing of a new agreement with Celltrion Healthcare Hungary Kft. (“Celltrion Healthcare”), a leading force in the biopharmaceutical industry. This agreement will make regdanvimab (CT-P59), a monoclonal antibody treatment for COVID-19, available for patients in Serbia and in the ex-Yugoslavia region.

industrial

Contact


+381 60 790 2200

Vlajkova St. 199, 16000 Leskovac, SerbiaMilutina Milankovica Blvd. 23, Belgrade, Serbia

info@zdravlje.co.rs